Improved Gastrointestinal Profile with Diroximel Fumarate is Associated with a Positive Impact on Quality of Life Compared with Dimethyl Fumarate: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study
Therapeutic advances in neurological disorders（2021）
关键词
clinical trial,diroximel fumarate,disease-modifying therapy,gastrointestinal,relapsing-remitting multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要